If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

Asian Journal of Andrology

Asian Journal of Andrology

Volume 9 Issue 3, Pages 403 - 407

Published Online: 9 May 2007

© 2008, Asian Journal of Andrology, SIMM and SJTU.



< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: PDF (Size: 95K)  | Related Articles | Citation Tracking

Yohimbine in the treatment of orgasmic dysfunction
Ade A. Adeniyi 1 , Giles S. Brindley 2 , John P. Pryor 1 , David J. Ralph 1
  1 Institute of Urology and Nephrology, London W1P 7EY, UK   2 102 Fer dene Road, London SE24 0AA, UK
 Correspondence to: Mr. David J. Ralph, Institute of Urology and Nephrology, 48 Riding House Street, London W1P 7EY, UK. Tel: +44-207-486-3805 Fax: +44-207-486-3810 E-mail: dralph@andrology.co.uk
Copyright 2007 Asian Journal of Andrology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
KEYWORDS
Yohimbine • anorgasmia • orgasm • orgasmic dysfunction • impotence • ejaculation

Abstract

AbstractReferences

Aim: To study the effect of yohimbine in the treatment of men with orgasmic dysfunction. Methods: A 20-mg dose of yohimbine was first given to 29 men with orgasmic dysfunction of different aetiology in the clinic. Patients were then allowed to increase the dose at home (titration) under more favourable circumstances. The outcome and side effects were subsequently assessed. Results: The patients were classified into three groups of orgasmic dysfunction: primary complete (13), primary incomplete (8) and secondary (8). Nocturnal emissions were present in 75%, 40% and 50% of patients in the above groups, respectively (overall average 62%). The men presented because of fertility problems (52%) or because they wanted to experience the pleasure of orgasm (48%). Of the 29 patients who completed the treatment, 16 managed to reach orgasm and were able to ejaculate either during masturbation or sexual intercourse. A further three achieved orgasm, but only with the additional stimulation of a vibrator. A history of preceding nocturnal emissions was present in 69% of the men in whom orgasm was induced but only 50% who failed treatment. Of the patients, two have subsequently fathered children (one set of twins) and another 3 men were also cured. Side effects were not sufficient to cause the men to cease treatment. Conclusion: Yohimbine is a useful treatment option in orgasmic dysfunction.


Received 2006-04-19 Accepted 2007-02-08

DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1745-7262.2007.00276.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Sign Up Now
Sign Up Now